Managing Psoriasis – Nurse Practitioner

  Price  

  Credits  1.5

This product is currently out of stock and unavailable.


Format
This issue will bring you up to date on the impact of Psoriasis and recent developments in drug therapy. Key Takeaways: • Psoriasis is recognized as an immunemediated, chronic, systemic inflammatory condition. • About 80% of patients with mild to moderate psoriasis can be managed well with topical medications. • Corticosteroids are the cornerstone of topical therapy. Psoriasis is the most common autoimmune condition in the US, affecting 7.5 million people. It is a complex, genetically linked disease; 1 in every 3 patients with psoriasis has a relative with the condition. The human and economic tolls are significant. Patients with psoriasis have lower quality of life scores, along with increased occurrences of depression, anxiety and suicidal ideation. In the US, more than $63 million is spent annually in direct healthcare costs for psoriasis. Currently, there is no cure; however, a variety of treatments (topical, systemic, phototherapy) are available to manage symptoms, minimize disease progression, and improve quality of life. Since the early 2000s, research into the immunopathogenesis of psoriasis has led to the development of biologic agents that target specific components of the immune system. Despite the availability of multiple treatments, patients with psoriasis in the US are often under treated, or untreated. Untreated or under treated psoriasis leads to disseminated disease and potentially, to joint impairment in the form of psoriatic arthritis (PsA), which causes pain and stiffness of affected joints. While psoriasis treatment guidelines recommend that trained specialty providers prescribe systemic therapies for patients with this disease, community practitioners should have a sufficient knowledge base to monitor treatment. Frequent patient interactions allow community practitioners, including pharmacists and nurse practitioners, to play an important role in psoriasis management. This issue will review basic information about cutaneous psoriasis and summarize various treatments so practitioners can better manage and educate patients...

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Nurse Practitioner

Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

  • Discuss the epidemiology and contributing factors for the development of psoriasis.
  • Describe psoriasis symptoms and how body surface area and the Psoriasis Area Severity Index (PASI) are used in assessing psoriasis severity.
  • List commonly used topical treatments. Counsel patients regarding administration, side effects, and precautions.
  • Compare and contrast systemic treatments used for psoriasis, including effectiveness, side effects, and precautions.

Course Accreditation

  • Activity Type:
    Knowledge
  • CE Broker
    0428-0000-18-007-H01-P
  • Universal Activity Number:
    Nurse Practitioner : 0428-0000-18-007-H01-P
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.